Acticor Biotech
Pre-clinicalActicor Biotech develops antibody-based treatments for acute ischemic stroke and other thrombotic diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $95M
About
Acticor Biotech develops antibody-based treatments for acute ischemic stroke and other thrombotic diseases.
AntibodiesBiologics
Funding History
6Total raised:$95M
Series B$25MJun 15, 2022
Series B$35MJun 15, 2022
Series A$15MDec 15, 2020
Series A$15MDec 15, 2020